Rebhan Dissertation ohne Lebenslauf - OPUS - Universität Würzburg

95. Doucet J, Gonzalez W, Michel JB. Endothelin antagonists in salt-
dependent hypertension associated with renal insufficiency. J Cardiovasc
Pharmacol 27: 643-51, 1996.
96. Ikeda T, Ohta H, Okada M, Kawai N, Nakao R, Siegl PK, Kobayashi T,
Maeda S, Miyauchi T, Nishikibe M. Pathophysiological roles of
endothelin-1 in Dahl salt-sensitive hypertension. Hypertension 34: 514-9,
1999.
97. Hocher B, George I, Rebstock J, Bauch A, Schwarz A, Neumayer HH,
Bauer C. Endothelin system-dependent cardiac remodeling in
renovascular hypertension. Hypertension 33: 816-22, 1999.
98. Sharifi AM, He G, Touyz RM, Schiffrin EL. Vascular endothelin-1
expression and effect of an endothelin ETA antagonist on structure and
function of small arteries from stroke-prone spontaneously hypertensive
rats. J Cardiovasc Pharmacol 31 Suppl 1: S309-S312, 1998.
99. Nishikibe M, Tsuchida S, Okada M, Fukuroda T, Shimamoto K, Yano M,
Ishikawa K, Ikemoto F. Antihypertensive effect of a newly synthesized
endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci
52: 717-24, 1993.
100. Douglas SA, Gellai M, Ezekiel M, Feuerstein GZ, Elliott JD, Ohlstein EH.
Antihypertensive actions of the novel nonpeptide endothelin receptor
antagonist SB 209670. Hypertension 25: 818-22, 1995.
101. Schiffrin EL, Turgeon A, Deng LY. Effect of chronic ETA-selective
endothelin receptor antagonism on blood pressure in experimental and
genetic hypertension in rats. Br J Pharmacol 121: 935-40, 1997.
102. Yu M, Gopalakrishnan V, McNeill JR. Hemodynamic effects of a
selective endothelin--a receptor antagonist in deoxycorticosterone
acetate-salt hypertensive rats. J Cardiovasc Pharmacol 31 Suppl 1:
S262-S264, 1998.